Sriram Rathi, pharma analyst at Anand Rathi is of the view that one may pick Cipla and Dr Reddys Laboratories from largecap pharma space.
Sriram Rathi, pharma analyst at Anand Rathi told CNBC-TV18, "In the largecap we are recommending Cipla and Dr Reddys Laboratories as our top picks and in the midcap space it is Indoco Remedies and Natco Pharma. Though the stocks have runup to some extent but I think it is more of a valuation narrowing which is happening and the discount which was prevailing in the largecaps as well as the midcap stocks."
At 12:12 hrs Natco Pharma was quoting at Rs 828.50, up Rs 22.30, or 2.77 percent. It has touched a 52-week high of Rs 839.90.
The share touched its 52-week high Rs 826 and 52-week low Rs 390 on 14 November, 2013 and 16 May, 2013, respectively. Currently, it is trading 0.3 percent below its 52-week high and 112.44 percent above its 52-week low. Market capitalisation stands at Rs 2,740.10 crore.
Exclusive offer: Use code "BUDGET2020" and get Moneycontrol Pro's Subscription for as little as Rs 333/- for the first year.